Helus Pharma is seeking review from the FDA for its drug candidate HLP003, led by company executive Eric So.
6 reports, 3 independent
Updated Oct 1
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 6
- Developments
- 3
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Helus Pharma is seeking review from the FDA for its drug candidate HLP003, led by company executive Eric So.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Helus Pharma is developing HLP004 for GAD and Embrace is a pivotal study for HLP003.1 source
Helus Pharma appoints Michael Halstead as CEO.1 source
Seeking FDA review for HLP003 drug candidate.1 source